CD30+, large T-cell lymphoma: Diagnostic distinction and management

Dermatology Online Journal

Volumn 12, Issue 6, 2006, Pages

  Parlette, Eric C ^a   Tabor, Camille A ^b  

^a US Naval Hospital   (Japan)

^b LHD 4   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; LEUKOCYTE ANTIGEN;

AGED; ALGORITHM; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; CANCER RADIOTHERAPY; CASE REPORT; CD34 SELECTION; DIAGNOSTIC TEST; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PUNCH BIOPSY; T CELL LYMPHOMA; DIFFERENTIAL DIAGNOSIS; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REMISSION; THIGH;

AGED; ANTIGENS, CD; CLOBETASOL; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, KI-1; REMISSION INDUCTION; REMISSION, SPONTANEOUS; THIGH;

EID: 33750966081     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Fung MA, Murphy MJ, Hoss DM, Grant-Kels JM. Practical evaluation and management of cutaneous lymphoma. J Am Acad Dermatol 2002; 46: 325-57.
2. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Paulli M, Meijer CJ, Willemze R. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. Cancer 1993; 71: 2097-104.
3. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. J Am Acad Dermatol 1993; 28: 973-80.
4. Krishnan J, Tomaszewski MM, Kao GF. Primary cutaneous CD30-positive anaplastic large cell lymphoma. Report of 27 cases. J Cutan Pathol 1993; 20: 193-202.
5. Camisa C, Helm TN, Sexton C, Tuthill R. Ki-1-positive anaplastic large-cell lymphoma can mimic benign dermatoses. J Am Acad Dermatol 1993; 29: 696-700.
6. Strutton G. Cutaneous infiltrates-lymphomatous and leukemic. In: Weedon D, Strutton G, eds. Skin pathology. 2nd ed. Edinburgh: Churchill Livingstone: 2002: 1095-1138.
7. Willemze R, Meijer CJLM. Primary cutaneous CD30-positive lymphoproliferative disorders. Hematol Oncol Clin N Am 2003; 17: 1319-32.
8. Bekkenk MW, Geelen FA, Van Voorst Vader PC, Heule F, Geerts M, Van Vloten WA, Meiher CJLM, Willemze R. Primary and secondary cutaneous CD30-positive lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653-61.
9. Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol 1996; 34: 470-81.
10. Paulli M, Berti E, Rosso R, Boveri E, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin - clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1995; 13: 1343-54.